KALA PHARMACEUTICALS INC's ticker is and the CUSIP is 483119953. A total of 3 filers reported holding KALA PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $20,000 | +1900.0% | 8,300 | +144.1% | 0.00% | – |
| Q2 2022 | $1,000 | -75.0% | 3,400 | +9.7% | 0.00% | – |
| Q1 2022 | $4,000 | 0.0% | 3,100 | -16.2% | 0.00% | – |
| Q4 2021 | $4,000 | -96.1% | 3,700 | -80.3% | 0.00% | – |
| Q3 2021 | $102,000 | +3.0% | 18,800 | 0.0% | 0.00% | – |
| Q2 2021 | $99,000 | -79.1% | 18,800 | +2570.5% | 0.00% | -100.0% |
| Q1 2021 | $474,000 | -35.9% | 704 | -35.5% | 0.00% | 0.0% |
| Q4 2020 | $739,000 | +559.8% | 1,091 | +627.3% | 0.00% | – |
| Q3 2020 | $112,000 | -72.9% | 150 | -61.9% | 0.00% | -100.0% |
| Q2 2020 | $414,000 | -2.8% | 394 | -18.8% | 0.00% | 0.0% |
| Q1 2020 | $426,000 | +1083.3% | 485 | +385.0% | 0.00% | – |
| Q4 2019 | $36,000 | +200.0% | 100 | +212.5% | 0.00% | – |
| Q3 2019 | $12,000 | -20.0% | 32 | +28.0% | 0.00% | – |
| Q2 2019 | $15,000 | +87.5% | 25 | +150.0% | 0.00% | – |
| Q1 2019 | $8,000 | – | 10 | +400.0% | 0.00% | – |
| Q4 2018 | $0 | -100.0% | 2 | -86.7% | 0.00% | – |
| Q3 2018 | $14,000 | -93.0% | 15 | -89.7% | 0.00% | -100.0% |
| Q2 2018 | $199,000 | +19800.0% | 145 | +1108.3% | 0.00% | – |
| Q1 2018 | $1,000 | – | 12 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| SIMPLEX TRADING, LLC | 3,400 | $1,000 | 0.00% |